Sichuan Renan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Chengdu Beite Pharmaceutical Co., Ltd., was established in August 2013. It is a high-tech enterprise dedicated to the R & D, production and sales of high-end APIs and intermediates. At present, Sichuan ren'an Pharmaceutical Co., Ltd. has two production bases, which are located in Yuechi County, Guang'an City, Sichuan Province and Qingbaijiang District, Chengdu City. Its headquarters is set up in Yuechi production base. Yuechi production base covers an area of 325 mu, with a construction area of 55636.83 square meters. It has 9 GMP production workshops, 1 pilot workshop and more than 700 employees. It mainly produces penicillin sterile API, cephalosporin non sterile API, ordinary non sterile API (including ephedrine), precursor API, etc. it has 55 API production approvals, of which 18 varieties have passed the national GMP certification and achieved industrial production, The sterile API "ampicillin sodium" has passed the two international GMP certification of EU and Japan. Qingbaijiang production base covers an area of 30 mu and a construction area of 6100 square meters. It has two GMP production workshops, mainly producing ordinary non sterile API. The company has established "Guang'an biomedical industry technology research institute" and "Guang'an academician expert workstation", which have made outstanding achievements in the field of API production process development. At present, 19 patents have been applied, 3 invention patents have been authorized and 7 utility model patents have been granted. It has been awarded "national high-tech enterprise", "Guang'an excellent private enterprise", "Guang'an innovation enterprise", "Sichuan Science Popularization demonstration enterprise" and other honors by national, provincial and municipal management departments at all levels. The company will continue to focus on the development concept of improving the core competitiveness of API, and strive to become a domestic first-class API manufacturer within 5 years under the guidance of the core values of "responsibility, enterprising, integrity and gratitude".